首页> 外文OA文献 >New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

【2h】

New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

机译：缺乏PPARγ激动剂活性的新的Troglitazone衍生物在激素依赖性和激素无关的乳腺癌细胞系中显示出增加的抗增殖效应

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Christelle Colin; Stéphane Salamone; Isabelle Grillier-Vuissoz; Michel Boisbrun; Sandra Kuntz; Julie Lecomte; Yves Chapleur; Stéphane Flament;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
专利

1. New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines [J] . Christelle Colin, Stéphane Salamone, Isabelle Grillier-Vuissoz, Breast Cancer Research and Treatment . 2010,第1期

机译：缺乏PPARγ激动剂活性的新曲格列酮衍生物在激素依赖性和激素依赖性乳腺癌细胞系中均显示出增加的抗增殖作用
2. New troglitazone derivatives devoid of PPARgamma agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines. [J] . Colin C, Salamone S, Grillier Vuissoz I, Breast cancer research and treatment. . 2010,第1期

机译：缺乏PPARγ激动剂活性的新曲格列酮衍生物在激素依赖性和激素依赖性乳腺癌细胞系中均显示出增加的抗增殖作用。
3. ATRA-hydrazonate derivatives and their copper complexes against hormone-dependent (MCF-7), hormone-independent (MDA-MB-231 and BT-20) breast cancer and androgen-independent (PC3) prostate cancer cell lines [J] . Alok Vyas, Sommai Patitungkho, Abeda Jamadar Inorganic Chemistry Communications . 2012,第Null期

机译：ATRA肼衍生物及其铜配合物可抵抗激素依赖性（MCF-7），激素依赖性（MDA-MB-231和BT-20）乳腺癌和雄激素依赖性（PC3）前列腺癌细胞系
4. Stilbene analogues as inhibitors of breast cancer Stem cells through P-glycoprotein efflux; A 3D quantitative structure-activity relationship study (Inhibitory activity of stilbenes analogues on breast cancer stem cells) [C] . Anushree Tripathi, Krishna Misra 2016 International Conference on Bioinformatics and Systems Biology . 2016

机译：Stilbene类似物通过P-糖蛋白外排作为乳腺癌干细胞的抑制剂； 3D定量结构-活性关系研究（Stilbenes类似物对乳腺癌干细胞的抑制活性）
5. Metabolic Engineering and Directed Evolution of Perillyl Alcohol Biosynthetic Pathway in Escherichia coli to Produce Compounds with Anti-cancer Activity Against Breast cancer cell lines. [D] . Gupta, Shweta. 2013

机译：代谢工程和大肠杆菌中紫苏氨醇生物合成途径的定向进化，以产生具有针对乳腺癌细胞系的抗癌活性的化合物。
6. The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent MEK-Dependent Pathway in Human Prostate Cancer Cells [O] . Adrienne Bolden, Lynikka Bernard, Danielle Jones, 2012

机译：PPARγ激动剂曲格列酮通过人类前列腺癌细胞中PPARγ独立MEK依赖性途径调节Erk 1/2磷酸化。
7. Unprecedented anticancer activities of organorhenium sulfonato and carboxylato complexes against hormone-dependent MCF-7 and hormone-independent triple-negative MDA-MB-231 breast cancer cells [O] . Paul T. Wilder, David J. Weber, Angela Winstead, 2017

机译：未证明的抗癌的抗核和羧基复合物对激素依赖性MCF-7和激素无关的三重阴性MDA-MB-231乳腺癌细胞

New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

摘要

著录项

相似文献

相关主题

期刊订阅